Neutrophilic disease of the skin and intestines after ipilimumab treatment for malignant melanoma - simultaneous occurrence of pyoderma gangrenosum and colitis

European Journal of Dermatology

Volumn 24, Issue 2, 2014, Pages 268-269

  Rudolph, Berenice M ^a   Staib, Frank ^a   Von Stebut, Esther ^a   Hainz, Michael ^a   Grabbe, Stephan ^a   Loquai, Carmen ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; CYTOKERATIN 8; IPILIMUMAB; MONOCLONAL ANTIBODY;

ADENOCARCINOMA; ADULT; ARTICLE; BONE METASTASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; LUNG METASTASIS; METASTASIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; SKIN BIOPSY; SKIN DEFECT; SKIN ULCER; UPPER EYELID; CHEMICALLY INDUCED; COLITIS; DRUG ERUPTIONS; IMMUNOLOGY; MELANOMA; NEUTROPHIL CHEMOTAXIS; PYODERMA GANGRENOSUM; SKIN NEOPLASMS;

ANTIBODIES, MONOCLONAL; COLITIS; DRUG ERUPTIONS; FEMALE; HUMANS; MELANOMA; MIDDLE AGED; NEUTROPHIL INFILTRATION; PYODERMA GANGRENOSUM; SKIN NEOPLASMS;

EID: 84901275236     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2014.2297     Document Type: Article

References (10)

1. Kahler KC, Hauschild A. Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma. J Dtsch Dermatol Ges 2011; 9: 277-86.
2. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711-23.
3. Robert C, Thomas L, Bondarenko I, et al. Ipilimumab plus darcabazin for previously untreated metastatic melanoma. N Engl J Med 2011; 364: 2517-26.
4. Simpson TR, Li F, Montalvo-Ortiz W, et al. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. J Exp Med 2013; 210: 1695-710.
5. Shahabi V, Berman D, Chasalow SD, et al. Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events. J Transl Med 2013; 11: 75.
6. Beck KE, Blansfield JA, Tran KQ, et al. Enterocolitis in PatientsWith Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte-Associated Antigen 4. J Clin Oncol 2006; 24: 2283-9.
7. Pintova S, Sidhu H, Friedlander PA, Holcombe RF. Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy. Melanoma Res 2013; 23: 498-501.
8. Wallach D, Vignon-Pennamen MD. From acute febrile neutrophilic dermatosis to neutrophilic disease: Forty years of clinical research. J Am Acad Dermatol 2006; 55: 1066-71.
9. Callen JP. Pyoderma gangrenosum. Lancet 1998; 351: 581-5.
10. Sherid M, Ehrenpreis ED. Types of colitis based on histology. Dis Mon 2011; 57: 457-89.